Kyverna Therapeutics (KYTX) Capital Leases (2023 - 2025)
Kyverna Therapeutics' (KYTX) quarterly Capital Leases came in at $8000.0 in Q3 2025, down 96.62% YoY from $237000.0 in Q3 2024, and down 69.23% on a QoQ basis from $26000.0 in Q2 2025.
Kyverna Therapeutics (KYTX) Capital Leases (2023 - 2025) Analysis & Trends
Kyverna Therapeutics (KYTX) has 3 years of Capital Leases data on file, last reported at $8000.0 in Q3 2025.
- Quarterly Capital Leases fell 96.62% year-over-year to $8000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was $8000.0 (down 96.62% YoY) and the FY2024 annual result came in at $142000.0, down 84.58% from the prior year.
- Capital Leases eased to $8000.0 in Q3 2025, from $26000.0 in the prior quarter.
- In the past five years, Capital Leases ranged from a high of $921000.0 in Q4 2023 to a low of $8000.0 in Q3 2025.
- A 3-year average of $310125.0 and a median of $189500.0 in 2024 frame the typical range for Capital Leases.
- Annual changes were most pronounced in 2024 — Capital Leases plunged 84.58% — and 2025, when it slumped 96.62%.
- Tracing KYTX's Capital Leases over 3 years: stood at $921000.0 in 2023, then tumbled by 84.58% to $142000.0 in 2024, then tumbled by 94.37% to $8000.0 in 2025.
- The last three Capital Leases figures came in at $8000.0 (Q3 2025), $26000.0 (Q2 2025), and $73000.0 (Q1 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 128.13 Bn | 120.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 112.33 Bn | 104.33 Bn | 3.93 Bn |
| 3 | Argenx Se | 53.24 Bn | 48.05 Bn | 1.41 Bn |
| 4 | Revolution Medicines | 43.64 Bn | 43.64 Bn | - |
| 5 | BeOne Medicines | 39.27 Bn | 34.17 Bn | 1.53 Bn |
| 6 | MindWalk Holdings | 35.32 Bn | 35.31 Bn | 1.82 Bn |
| 7 | Royalty Pharma | 33.72 Bn | 35.84 Bn | - |
| 8 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 9 | Insmed | 27.01 Bn | 25.85 Bn | 358.27 Mn |
| 10 | Kyverna Therapeutics | 505.26 Mn | 505.26 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 8,000.00 |
| Jun 30, 2025 | 26,000.00 |
| Mar 31, 2025 | 73,000.00 |
| Dec 31, 2024 | 142,000.00 |
| Sep 30, 2024 | 237,000.00 |
| Jun 30, 2024 | 407,000.00 |
| Mar 31, 2024 | 667,000.00 |
| Dec 31, 2023 | 921,000.00 |